Cutaneous reactions induced by oxcarbazepine in Southern Han Chinese: Incidence, features, risk factors and relation to HLA-B alleles

Seizure

Volumn 21, Issue 8, 2012, Pages 614-618

  He, Na ^a   Min, Fu Li ^a   Shi, Yi Wu ^a   Guo, Jing ^a   Liu, Xiao Rong ^a   Li, Bing Mei ^a   Zhou, Jin Hua ^b   Ou, Yang Mei ^b   Liao, Jian Xiang ^c   Liao, Wei Ping ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b Guangdong 999 Brain Hospital   (China)

^c SHENZHEN CHILDREN'S HOSPITAL   (China)

Author keywords

1502; HLA B; Incidence; Maculopapular eruption; Oxcarbazepine; Risk factors

Indexed keywords

HLA B ANTIGEN; OXCARBAZEPINE;

ADULT; ALLERGY; ARTICLE; CHINESE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG ERUPTION; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADULT; ALLELES; ANTICONVULSANTS; ASIAN CONTINENTAL ANCESTRY GROUP; CARBAMAZEPINE; CHILD; DRUG ERUPTIONS; FEMALE; HLA-B ANTIGENS; HUMANS; INCIDENCE; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS;

EID: 84865227476     PISSN: 10591311     EISSN: 15322688     Source Type: Journal    
DOI: 10.1016/j.seizure.2012.06.014     Document Type: Article

References (36)

1. S.C. Schachter Oxcarbazepine: current status and clinical applications Expert Opinion on Investigational Drugs 8 1999 1103 1112
2. J.W. McAuley, T.S. Biederman, J.C. Smith, and J.L. Moore Newer therapies in the drug treatment of epilepsy Annals of Pharmacotherapy 36 2002 119 129
3. M.M. Kalis, and N.A. Huff Oxcarbazepine, an antiepileptic agent Clinical Therapeutics 23 2001 680 700
4. L.J. Hirsch, H. Arif, E.A. Nahm, R. Buchsbaum, S.R. Resor Jr., and C.W. Bazil Cross-sensitivity of skin rashes with antiepileptic drug use Neurology 71 2008 1527 1534
5. S. Alvestad, S. Lydersen, and E. Brodtkorb Rash from antiepileptic drugs: influence by gender, age, and learning disability Epilepsia 48 2007 1360 1365
6. X.Q. Wang, S.Y. Lang, X.B. Shi, H.J. Tian, R.F. Wang, and F. Yang Antiepileptic drug-induced skin reactions: a retrospective study and analysis in 3793 Chinese patients with epilepsy Clinical Neurology and Neurosurgery 2012 10.1016/j.clineuro.2012.01.019 Feb 7
7. L.C. Lin, P.C. Lai, S.F. Yang, and R.C. Yang Oxcarbazepine-induced Stevens-Johnson syndrome: a case report Kaohsiung Journal of Medical Sciences 25 2009 82 86
8. S.I. Hung, W.H. Chung, Z.S. Liu, C.H. Chen, M.S. Hsih, and R.C. Hui Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese Pharmacogenomics 11 2010 349 356
9. E. Bosdure, A. Cano, B. Roquelaure, R. Reynaud, M. Boyer, and L. Viard Oxcarbazepine and DRESS syndrome: a paediatric cause of acute liver failure Archives de Pediatrie 11 2004 1073 1077
10. J.L. D'Orazio Oxcarbazepine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) Clinical Toxicology (Philadelphia) 46 2008 1093 1094
11. J.C. Chakarian, C. Girault, G. Beduneau, A.B. Duval-Modeste, P. Joly, and G. Bonmarchand Oxcarbazepine drug rash with eosinophilia and systemic symptoms (DRESS) syndrome mimicking septic shock Presse Medicale 39 2010 1103 1105
12. G. Zaccara, D. Franciotta, and E. Perucca Idiosyncratic adverse reactions to antiepileptic drugs Epilepsia 48 2007 1223 1244
13. F.Y. Hu, X.T. Wu, D.M. An, B. Yan, H. Stefan, and D. Zhou Pilot association study of oxcarbazepine-induced mild cutaneous adverse reactions with HLA-B*1502 allele in Chinese Han population Seizure 20 2011 160 162
14. S.R. Knowles, L.E. Shapiro, and N.H. Shear Anticonvulsant hypersensitivity syndrome: incidence, prevention and management Drug Safety 21 1999 489 501
15. J.C. Roujeau The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classification Journal of Investigative Dermatology 102 1994 28S 30S
16. E. Trachtenberg, M. Vinson, E. Hayes, Y.M. Hsu, K. Houtchens, and H. Erlich HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1 DPB1) alleles and haplotypes in the Han from southern China Tissue Antigens 70 2007 455 463
17. F.F. Gonzalez-Galarza, S. Christmas, D. Middleton, and A.R. Jones Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations Nucleic Acids Research 39 2011 D913 D919
18. Y.W. Shi, F.L. Min, X.R. Liu, L.X. Zan, M.M. Gao, and M.J. Yu HLA-B alleles and lamotrigine-induced cutaneous adverse drug reactions in the Han Chinese population Basic and Clinical Pharmacology and Toxicology 109 2011 42 46
19. N.P. Jewell On the bias of commonly used measures of association for 2 × 2 tables Biometrics 42 1986 351 358
20. Y. Buggy, D. Layton, C. Fogg, and S.A. Shakir Safety profile of oxcarbazepine: results from a prescription-event monitoring study Epilepsia 51 2010 818 829
21. J. Messenheimer, E.L. Mullens, L. Giorgi, and F. Young Safety review of adult clinical trial experience with lamotrigine Drug Safety 18 1998 281 296
22. A. Beydoun, R.C. Sachdeo, W.E. Rosenfeld, G.L. Krauss, N. Sessler, and P. Mesenbrink Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial Neurology 54 2000 2245 2251
23. L.J. Hirsch, D.B. Weintraub, R. Buchsbaum, H.T. Spencer, T. Straka, and M. Hager Predictors of lamotrigine-associated rash Epilepsia 47 2006 318 322
24. R. Maganti, B.E. Gidal, R. Shaw, and P. Rutecki Concomitant use of divalproex sodium and lamotrigine in developmentally disabled patients with epilepsy: a retrospective evaluation of efficacy and tolerability Epilepsy and Behavior 3 2002 275 279
25. I.C. Wong, G.E. Mawer, and J.W. Sander Factors influencing the incidence of lamotrigine-related skin rash Annals of Pharmacotherapy 33 1999 1037 1042
26. M.J. Brodie, P.W. Overstall, and L. Giorgi Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy The UK Lamotrigine Elderly Study group Epilepsy Research 37 1999 81 87
27. H. Arif, R. Buchsbaum, D. Weintraub, S. Koyfman, C. Salas-Humara, and C.W. Bazil Comparison and predictors of rash associated with 15 antiepileptic drugs Neurology 68 2007 1701 1709
28. S. Alvestad, S. Lydersen, and E. Brodtkorb Cross-reactivity pattern of rash from current aromatic antiepileptic drugs Epilepsy Research 80 2008 194 200
29. X.Q. Wang, S.Y. Lang, X.B. Shi, H.J. Tian, R.F. Wang, and F. Yang Cross-reactivity of skin rashes with current antiepileptic drugs in Chinese population Seizure 19 2010 562 566
30. W.H. Chung, S.I. Hung, H.S. Hong, M.S. Hsih, L.C. Yang, and H.C. Ho Medical genetics: a marker for Stevens-Johnson syndrome Nature 428 2004 486
31. S.I. Hung, W.H. Chung, S.H. Jee, W.C. Chen, Y.T. Chang, and W.R. Lee Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions Pharmacogenet Genomics 16 2006 297 306
32. Q. Wang, J.Q. Zhou, L.M. Zhou, Z.Y. Chen, Z.Y. Fang, and S.D. Chen Association between HLA-B*1502 allele and carbamazepine-induced severe cutaneous adverse reactions in Han people of southern China mainland Seizure 20 2011 446 448
33. X.T. Wu, F.Y. Hu, D.M. An, B. Yan, X. Jiang, and P. Kwan Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China Epilepsy and Behavior 19 2010 405 408
34. D.M. An, X.T. Wu, F.Y. Hu, B. Yan, H. Stefan, and D. Zhou Association study of lamotrigine-induced cutaneous adverse reactions and HLA-B*1502 in a Han Chinese population Epilepsy Research 92 2010 226 230
35. C.B. Man, P. Kwan, L. Baum, E. Yu, K.M. Lau, and A.S. Cheng Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese Epilepsia 48 2007 1015 1018
36. G.R. Kazeem, C. Cox, J. Aponte, J. Messenheimer, C. Brazell, and A.C. Nelsen High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients Pharmacogenet Genomics 19 2009 661 665